These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 23977280)
1. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood. Adamaki M; Lambrou GI; Athanasiadou A; Tzanoudaki M; Vlahopoulos S; Moschovi M PLoS One; 2013; 8(8):e72326. PubMed ID: 23977280 [TBL] [Abstract][Full Text] [Related]
2. HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival. Adamaki M; Lambrou GI; Athanasiadou A; Vlahopoulos S; Papavassiliou AG; Moschovi M Leuk Res; 2015 Aug; 39(8):874-82. PubMed ID: 26059450 [TBL] [Abstract][Full Text] [Related]
3. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome. Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790 [TBL] [Abstract][Full Text] [Related]
4. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Zhang L; Taub JW; Williamson M; Wong SC; Hukku B; Pullen J; Ravindranath Y; Matherly LH Clin Cancer Res; 1998 Sep; 4(9):2169-77. PubMed ID: 9748136 [TBL] [Abstract][Full Text] [Related]
5. Aberrant AML1 gene expression in the diagnosis of childhood leukemias not characterized by AML1-involved cytogenetic abnormalities. Adamaki M; Vlahopoulos S; Lambrou GI; Papavassiliou AG; Moschovi M Tumour Biol; 2017 Mar; 39(3):1010428317694308. PubMed ID: 28349830 [TBL] [Abstract][Full Text] [Related]
6. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup. Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494 [TBL] [Abstract][Full Text] [Related]
7. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587 [TBL] [Abstract][Full Text] [Related]
8. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT Biochim Biophys Acta; 2010 Feb; 1802(2):292-300. PubMed ID: 19897031 [TBL] [Abstract][Full Text] [Related]
9. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT Blood; 2003 Jul; 102(1):262-8. PubMed ID: 12637319 [TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789 [TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722 [TBL] [Abstract][Full Text] [Related]
13. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720 [TBL] [Abstract][Full Text] [Related]
14. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia. Umiel T; Pattengale P; Weinberg K Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914 [TBL] [Abstract][Full Text] [Related]
16. Deletions of the p16 gene in pediatric leukemia and corresponding cell lines. Kees UR; Ranford PR; Hatzis M Oncogene; 1996 May; 12(10):2235-9. PubMed ID: 8668350 [TBL] [Abstract][Full Text] [Related]
17. Differential WNT gene expression in various subtypes of acute lymphoblastic leukemia. Memarian A; Vosough P; Asgarian-Omran H; Tabrizi M; Shabani M; Shokri F Iran J Immunol; 2012 Mar; 9(1):61-71. PubMed ID: 22426169 [TBL] [Abstract][Full Text] [Related]
18. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia. Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033 [TBL] [Abstract][Full Text] [Related]
19. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes. Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]